Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu INRA logo envt small Logo INP-EI Purpan Logo UPS-Tlse3

Home page

Zone de texte éditable et éditée et rééditée

Titanium dioxide does not weaken intestinal mucus

Muqueuse intestinale
© Inra
INRA TOXALIM and MICALIS research units, in collaboration with CNRS teams, investigated the potential effects on the intestinal mucus of TiO2, an additive present in nanoparticulate form in foods. Their results have just been published in the Journal of Nanobiotechnology.

Titanium dioxide (TiO2) is a food additive commonly used in confectionery under the code E171. Toxalim, the research centre on food toxicology of Inra Occitanie-Toulouse, has been working for a long time on this element and its interactions with the digestive system. The risk of disruption of the intestinal barrier is indeed high when the molecule is present in nanoparticulate form.

  • A collaboration between two INRA research units (TOXALIM Toulouse and MICALIS Jouy-en-Josas) and CNRS teams has tested the potential interaction of these nanoparticles with mucus, a key player in the barrier function of the intestine, which acts not only as a selective filter but also as an ecological niche for the gut microbiota.
  • Researchers conducted experiments in both artificial (in vitro) and rat (in vivo) media. They used mucus-secreting intestinal cells for this purpose, and used the natural fluorescence of TiO2 to study it under a confocal microscope.
    • After one hour of exposure, an accumulation of E171 particles was observed in the mucus.
  • The experiment was continued in vivo with a daily oral exposure of the rat at levels similar to those described in humans (0.1 and 10 mg / kg body weight / day), either over one week or over two months.
    • Regardless of the treatment considered, two key parameters of intestinal mucus functionality, namely the nature of mucin sugars, as well as short chain fatty acid levels, remain unchanged.
443253-9985a-picture_original-schema-mucus